Literature DB >> 22503393

Enterohepatic Helicobacter spp. in colonic biopsies of dogs: molecular, histopathological and immunohistochemical investigations.

V Castiglioni1, R Vailati Facchini, S Mattiello, M Luini, V Gualdi, E Scanziani, C Recordati.   

Abstract

Enterohepatic Helicobacter spp. have been described colonizing the large intestine and liver of healthy and symptomatic subjects and are thought to have a role in the development of inflammatory bowel disease (IBD). The prevalence of enterohepatic Helicobacter spp. infection in dogs is largely unknown and to our knowledge there are no data about their potential pathogenic role. In light of these considerations, the aims of this study were (i) to assess the prevalence of enterohepatic Helicobacter spp. in colonic biopsies of symptomatic pet dogs and (ii) to evaluate a possible association between Helicobacter spp. colonization status (heavily colonized, poorly colonized and uncolonized biopsies) and histological lesions. Colonic biopsies from 27 pet dogs of different ages were evaluated by family Helicobacteraceae and enterohepatic Helicobacter spp. PCR, histology, and immunohistochemistry for the in situ detection of Helicobacter spp. organisms. 85% and 52% of colonic biopsies were positive by Helicobacteraceae and enterohepatic Helicobacter spp. PCR, respectively. Immunohistochemistry revealed Helicobacter spp. were localized both in the superficial mucus (55%) and within intestinal crypts (33%). Dogs with heavy enterohepatic Helicobacter spp. colonization were significantly younger and had a higher level of mucosal fibrosis/atrophy than dogs with uncolonized or poorly colonized biopsies (p<0.05). These findings contribute to widen current knowledge regarding canine enterohepatic Helicobacter spp., suggesting the infection is rather common in dogs and acquired at an early age. Furthermore, heavy colonization of colonic crypts is associated with chronic inflammatory lesions (fibrosis/atrophy), supporting the role of enterohepatic Helicobacter spp. in the development of canine IBD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503393     DOI: 10.1016/j.vetmic.2012.03.026

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Identification of Helicobacter spp. in gastrointestinal tract, pancreas and hepatobiliary system of stray cats.

Authors:  A Shojaee Tabrizi; A Derakhshandeh; A Esfandiari; Z Ali Atashi
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

2.  IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy.

Authors:  Federica Riva; Laura Bianchessi; Camilla Recordati; Alessia Inglesi; Vittoria Castiglioni; Lauretta Turin
Journal:  Vet Sci       Date:  2022-06-14

3.  Helicobacter genus in the intestine and liver of stray cats: the molecular, histopathological, and immunohistochemical study.

Authors:  Boshra Elyasi; Annahita Rezaie; Naghmeh Moori Bakhtiari; Bahman Mosallanejad
Journal:  Braz J Microbiol       Date:  2020-09-01       Impact factor: 2.476

4.  Detection of Helicobacter spp. DNA in the colonic biopsies of stray dogs: molecular and histopathological investigations.

Authors:  Fatemeh Soghra Abdi; Shahram Jamshidi; Farhad Moosakhani; Farhang Sasani
Journal:  Diagn Pathol       Date:  2014-03-06       Impact factor: 2.644

5.  Preclinical evaluation of anti-Helicobacter spp. activity of Hippocratea celastroides Kunth and its acute and sub-acute toxicity.

Authors:  Griselda García-Alonso; Antonio Monroy-Noyola; Armando Contreras-Arellano; José Fernando Mariscal-Durand; Yolanda Gálvez-Molina; Alejandro Vázquez-Velázquez; Sara García-Jimenez; Pablo Nuñez; Alexandre Cardoso-Taketa; María Luisa Villarreal
Journal:  BMC Complement Altern Med       Date:  2016-11-08       Impact factor: 3.659

6.  Keratin 8 reduces colonic permeability and maintains gut microbiota homeostasis, protecting against colitis and colitis-associated tumorigenesis.

Authors:  Chao Liu; En-Dong Liu; Yun-Xiao Meng; Xiao-Ming Dong; Ya-Lan Bi; Huan-Wen Wu; Yan-Chao Jin; Ke Zhao; Jian-Jie Li; Miao Yu; Yi-Qun Zhan; Hui Chen; Chang-Hui Ge; Xiao-Ming Yang; Chang-Yan Li
Journal:  Oncotarget       Date:  2017-05-27

7.  Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.

Authors:  Minna Wu; Yaqi Wu; Baoguo Deng; Jinsong Li; Haiying Cao; Yan Qu; Xinlai Qian; Genshen Zhong
Journal:  Oncotarget       Date:  2016-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.